RARE vs STEM · rev $560.2M vs rev $144.6M
Ultragenyx (RARE) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
RARE currently screens at market cap $2.79B. STEM currently screens at market cap $82.1M.
Not investment advice. Open the RARE and STEM stock pages for the full models.
Not investment advice.